FirstGroup PLC

AGM Information • Jun 26, 2025

FirstGroup plc Notice of Annual General Meeting 2025

Friday 25 July 2025 at 2.30 pm

Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London, SW1P 3EE

The AGM this year will be a physical meeting.

A Form of Proxy is enclosed with this Notice of AGM and instructions for its completion and return by post or online are shown on the form. You can vote online by logging on to your portfolio at www.shareview.co.uk Shareholders are strongly encouraged to return their Form of Proxy completed in favour of the Chair of the meeting or vote online in advance of the AGM.

Shareholders who wish to ask a question of the Board relating to the business of the AGM are encouraged to do so by submitting questions in advance of the AGM by email to companysecretariat@firstgroup.co.uk.

This document and the accompanying Form of Proxy are important and require your immediate attention.

If you are in any doubt as to any aspect of the proposals referred to in this document, or as to the action you should take, you should seek your own personal financial advice immediately from an independent professional adviser authorised under the Financial Services and Markets Act 2000 if you are resident in the United Kingdom or, if not, from another appropriately authorised independent professional adviser.

If you have sold or otherwise transferred all of your ordinary shares in FirstGroup plc, you should send this document, but not the personalised Form of Proxy at once to the purchaser or transferee, or to the person who arranged the sale or transfer, so they can pass this document to the person who now holds the shares. If you sell or have sold part only of your holding of ordinary shares in FirstGroup plc, please consult the bank, stockbroker or other agent through whom the sale or transfer was effected.

Notice of Annual General Meeting

NOTICE IS HEREBY GIVEN that the Annual General Meeting ('AGM') of FirstGroup plc will be held at Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London, SW1P 3EE on Friday 25 July 2025 at 2.30 pm to consider and, if thought fit, pass the following resolutions of which resolutions 1 to 14 (inclusive) and 18 to 19 will be proposed as ordinary resolutions, and resolutions 15 to 17 (inclusive) and 20 will be proposed as special resolutions.

The Board considers that all of the resolutions are in the best interests of the Company and its shareholders as a whole and unanimously recommends shareholders to vote in favour of the resolutions as they intend to do in respect of their own beneficial holdings.

• 1 To receive the reports of the Directors and auditors and the audited financial statements of the Company for the 52 weeks ended 29 March 2025.
• 2 To approve the Directors' Annual Report on Remuneration for the 52 weeks ended 29 March 2025 set out on pages 91 to 114 (inclusive) of the 2025 Annual Report and Financial Statements.
• 3 To declare a final dividend of 4.8 pence per ordinary share for the 52 weeks ended 29 March 2025.
• 4 To re‑elect Sally Cabrini as a Director.
• 5 To re‑elect Myrtle Dawes as a Director.
• 6 To re‑elect Claire Hawkings as a Director.
• 7 To re‑elect Jane Lodge as a Director.
• 8 To re‑elect Peter Lynas as a Director.
• 9 To re‑elect Ryan Mangold as a Director.
• 10 To re‑elect Graham Sutherland as a Director.
• 11 To elect Lena Wilson as a Director.
• 12 To re-appoint PricewaterhouseCoopers LLP as auditors of the Company until the conclusion of the next general meeting at which accounts are laid.
• 13 To authorise the Directors to determine the remuneration of the auditors.
• 14 That the Board be authorised to allot shares in the Company and to grant rights to subscribe for or convert any security into shares in the Company:
  • (A) up to an aggregate nominal amount of £9,749,508.35 (such amount to be reduced by the nominal amount allotted or granted under paragraph (B) below in excess of such sum); and
  • (B) comprising equity securities (as defined in section 560(1) of the Companies Act 2006) (the '2006 Act') up to an aggregate nominal amount of £19,499,016.70 (such amount to be reduced by any allotments or grants made under paragraph (A) above) in connection with a pre‑emptive offer (including an offer by way of a rights issue or an open offer):
• I. to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
• II. to holders of other equity securities as required by the rights of those securities or as the Board otherwise considers necessary,

and so that the Board may impose any limits or restrictions and make any arrangements which it considers necessary or appropriate to deal with treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or under the laws of, any territory or any

other matter, such authorities to apply until the end of the next AGM of the Company in 2026 (or, if earlier, on 24 October 2026) but, in each case, during this period the Company may make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after the authority ends and the Board may allot shares or grant rights to subscribe for or convert securities into shares under any such offer or agreement as if the authority had not ended.

15 That if Resolution 14 is passed, the Board be given power to allot equity securities (as defined in the 2006 Act) for cash under authority given by that resolution and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the 2006 Act did not apply to any such allotment or sale, such power to be limited:

• (A) to the allotment of equity securities and sale of treasury shares for cash in connection with an offer of, or invitation to apply for, equity securities (but in the case of the authority granted under paragraph (B) of Resolution 14 by way of a pre‑emptive offer (including an offer by way of a rights issue or an open offer)):
• I. to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
• II. to holders of other equity securities, as required by the rights of those securities or, as the Board otherwise considers necessary,

and so that the Board may impose any limits or restrictions and make any arrangements which it considers necessary or appropriate to deal with treasury shares, fractional entitlements, record dates, legal, regulatory or practical problems in, or under the law of, any territory or any other matter;

• (B) in the case of authority granted under paragraph (A) of Resolution 14 and/or in the case of any sale of treasury shares for cash, to the allotment (otherwise than under paragraph (A) above) of equity securities or sale of treasury shares up to a nominal amount of £2,924,852.50; and
• (C) to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph (A) or paragraph (B) above) up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph (B) above, such power to be used only for the purposes of making a follow‑on offer which the Board determines to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre‑Emption Rights most recently published by the Pre‑Emption Group prior to the date of this Notice;

such power to apply until the end of the next AGM of the Company in 2026 (or, if earlier, on 24 October 2026) but during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or arrangement as if the power had not ended.

• 16 That if Resolution 14 is passed, the Board be given power in addition to any power given under Resolution 16 to allot equity securities (as defined in the 2006 Act) for cash under the authority given by Resolution 15 and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the 2006 Act did not apply to such allotment or sale, such power to be:
  • (A) limited to the allotment of equity securities or sale of treasury shares up to a nominal amount of £2,924,852.50, such power to be used only for the purposes of financing a transaction which the Board determines to be either an acquisition or a specified capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre‑Emption Rights most recently published by the Pre‑Emption Group prior to the date of this Notice or for the purposes of refinancing such a transaction within 12 months of its taking place; and
  • (B) limited to the allotment of equity securities or sale of treasury shares (otherwise than under paragraph (A) above) up to a nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph (A) above, such power to be used only for the purposes of making a follow‑on offer which the Board determines to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre‑Emption Rights most recently published by the Pre‑Emption Group prior to the date of this Notice,

such power to apply until the end of the next AGM of the Company in 2026 (or, if earlier, on 24 October 2026) (unless previously revoked or varied by the Company in a general meeting) but during this period the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the power ends and the Board may allot equity securities (and sell treasury shares) under any such offer or arrangement as if the power had not ended.

• 17 That the Company be authorised for the purposes of section 701 of the 2006 Act to make one or more market purchases (as defined in section 693(4) of the 2006 Act) of its ordinary shares of 5 pence each, such power to be limited:
  • (A) to a maximum aggregate number of 87,678,078 ordinary shares; and
  • (B) by the condition that the minimum price which may be paid for an ordinary share is 5 pence and the maximum price which may be paid for an ordinary share is the highest of:
• I. an amount equal to 5% above the average market value of an ordinary share as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which that ordinary share is contracted to be purchased; and
• II. the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venues where the purchase is carried out, in each case, exclusive of expenses,

such power to apply until the end of the next AGM of the Company in 2026 (or, if earlier, on 24 October 2026) (unless previously revoked or varied by the Company in a general meeting) but, in each case, so that the Company may enter into a contract to purchase ordinary shares which will or may be completed or executed wholly or partly after the power ends and the Company may purchase ordinary shares pursuant to any such contract as if the power had not ended.

• 18 That in accordance with sections 366 and 367 of the 2006 Act the Company and all companies that are subsidiaries of the Company at any time during the period commencing on the date of this resolution and ending at the conclusion of the next AGM of the Company in 2026 or, if earlier, on 24 October 2026 be and are hereby authorised:
  • (A) to make political donations to political parties and/or independent election candidates;
  • (B) to make political donations to political organisations other than political parties; and
  • (C) to incur political expenditure, up to an aggregate amount of £100,000.

Words and expressions defined for the purpose of the 2006 Act shall have the same meaning in this resolution.

All existing authorisations and approvals relating to political donations or expenditure under Part 14 of the 2006 Act are hereby revoked without prejudice to any donation made or expenditure incurred prior to the date hereof pursuant to such authorisation or approval.

• 19 (A) That the FirstGroup plc Sharesave Plan 2025 (the "Sharesave"), summarised in Appendix 2 to this Notice and the rules of which are produced to this meeting and for the purposes of identification initialled by the Chair, be approved and the Board be authorised to do all such acts and things necessary or desirable to establish the Sharesave; and
  • (B) That the Board be authorised to adopt further plans based on the Sharesave but modified to take account of local tax, exchange control or securities laws in overseas territories, provided that any cash or shares made available under such further plans are treated as counting against any limits on individual or overall participation in the Sharesave.
• 20 That a general meeting other than an AGM may be called on not less than 14 clear days' notice.

By order of the Board

David Blizzard

Company Secretary

20 June 2025

No. SC157176

Registered office: 395 King Street, Aberdeen AB24 5RP Registered in Scotland

Explanatory notes to the business of the meeting

Resolution 1

Annual Report and Financial Statements

The Board asks that shareholders receive the reports of the Directors and auditors and the audited financial statements of the Company for the 52 weeks ended 29 March 2025.

Resolution 2

Directors' Annual Report on Remuneration

Resolution 2 seeks shareholder approval of the Directors' Annual Report on Remuneration (including the Statement by the Chair of the Remuneration Committee) which can be found on pages 91 to 114 (inclusive) of the 2025 Annual Report and Financial Statements. The Directors' Annual Report on Remuneration gives details of the implementation of the Company's existing Remuneration Policy approved by shareholders at the 2024 AGM, which is available at www.firstgroupplc.com/investors. The vote on Resolution 2 is advisory in nature.

Resolution 3 Final Dividend

The Board recommends a final dividend of 4.8 pence per ordinary share for the 52 weeks ended 29 March 2025. If approved by shareholders, the recommended dividend will be paid on 8 August 2025 to all shareholders on the register at the close of business on 4 July 2025.

Resolutions 4 to 11 Election and Re‑election of Directors

In accordance with the recommendations contained in the UK Corporate Governance Code (the 'Code'). Sally Cabrini, Myrtle Dawes, Claire Hawkings, Jane Lodge and Peter Lynas, who are standing for re‑election at the AGM (Resolutions, 4, 5, 6, 7 and 8) are believed by the Board to be independent in character and judgement and that there are no relationships or circumstances likely to affect their independence or judgement. Independence provisions only apply to the Chair (Resolution 11) on appointment, and Lena Wilson was considered by the Board to be independent on appointment. They do not apply to the Executive Directors (Resolutions 9 and 10).

The Board believes that each Director standing for election or re‑election continues to bring considerable and wide‑ranging skills and experience to the Board as a whole and therefore recommends their election or re‑election.

All Directors proposed for election or re‑election are subject to an annual performance review and the Board confirms that they all make an effective and valuable contribution to the deliberations of the Board and demonstrate commitment to their roles.

Biographical details of our Directors standing for election or re‑election are set out in Appendix 1 and on pages 74 to 76 of the 2025 Annual Report and Financial Statements.

Resolutions 12 and 13

Re‑appointment and remuneration of Auditor

The Company is required at each general meeting at which accounts are presented to shareholders to re-appoint auditors to hold office until the next such meeting. Resolution 12, which has been recommended to the Board by the Audit Committee, seeks the re‑appointment of PricewaterhouseCoopers LLP as the Company's external auditor.

It is normal practice for the Directors to be authorised to determine the level of the auditor's remuneration for the ensuing year and Resolution 13 proposes to give such authority, which the Board will delegate to the Audit Committee.

Resolution 14 Authority to allot shares

Paragraph (A) of this resolution would give the Directors the authority to allot shares or grant rights to subscribe for or convert any securities into shares up to an aggregate nominal amount equal to £9,749,508.35 (representing 194,990,167 ordinary shares of 5 pence each). This amount represents approximately one‑third of the issued ordinary share capital (excluding treasury shares) of the Company as at 19 June 2025, the latest practicable date prior to publication of this Notice.

Paragraph (B) of this resolution would give the Directors authority to allot shares or grant rights to subscribe for or convert any securities into shares) in connection with a pre‑emptive offer (including an offer by way of a rights issue or an open offer), in favour of ordinary shareholders up to an aggregate nominal amount equal to £19,499,016.70 (representing 389,980,334 ordinary shares), as reduced by the nominal amount of any shares issued under paragraph (A) of this resolution. This amount (before any reduction) represents approximately two‑thirds of the issued ordinary share capital (excluding treasury shares) of the Company as at 19 June 2025, the latest practicable date prior to publication of this Notice.

The authority sought under this resolution will expire at the earlier of 24 October 2026 and the conclusion of the AGM of the Company held in 2026. The Directors have no present intention to exercise the authority sought under this resolution. As at the date of this Notice, 165,724,514 ordinary shares are held by the Company in treasury.

Resolutions 15 and 16 Disapplication of pre‑emption rights

Resolutions 15 and 16 will both be proposed as special resolutions, each of which requires a 75% majority of the votes to be cast in favour. They would give the Directors the power to allot ordinary shares (or sell any ordinary shares which the Company holds in treasury) for cash without first offering them to existing shareholders in proportion to their existing shareholdings.

The power set out in Resolution 15 would be limited to:

• (a) pre‑emptive offers, including rights issues or open and offers to holders of other equity securities if required by the rights of those shares or as the Board otherwise considers necessary;
• (b) otherwise, allotments or sales up, up to an aggregate nominal amount of £2,944,852.50 (representing 58,497,050 ordinary shares and approximately 10% of the issued ordinary share capital (excluding treasury shares) of the Company as at 19 June 2025, the latest practicable date prior to the publication of this Notice); and
• (c) allotments or sales up to an additional aggregate nominal amount equal to 20% of any allotments or sales made under (b) above (so a maximum of 2%), such power to be used only for the purposes of making a follow‑on offer of a kind contemplated by Section 2B of the Pre‑emption Group's Statement of Principles 2022.

Resolution 16 is intended to give the Company flexibility to make non‑pre‑emptive issues of ordinary shares in connection with acquisitions and specified capital investments as contemplated by the Pre‑emption Group's Statement of Principles 2022. The power under resolution 16 is in addition to that proposed by resolution 15 and would be limited to:

• (i) allotments or sales of up to an aggregate nominal amount of £2,944,852.50 (representing 58,497,050 ordinary shares and an additional 10% of the issued ordinary share capital of the Company (excluding treasury shares) as at 19 June 2025, the latest practicable date prior to publication of this Notice); and
• (ii) allotments or sales up to an additional aggregate nominal amount equal to 20% of any allotments or sales made under (a) above (so a maximum of 2%), such power to be used only for the purposes of making a follow‑on offer of a kind contemplated by Section 2B of the Pre‑emption Group's Statement of Principles 2022.

The limits in Resolutions 15 and 16 are in line with those set out in the Pre‑Emption Group's Statement of Principles 2022.

The Board considers the authority in these two resolutions to be appropriate in order to allow the Company flexibility to finance business opportunities or to conduct a pre‑emptive offer or rights issue without the need to comply with the strict requirements of the statutory pre‑emptive provisions. The Board has no present intention to make use of this authority. If the powers sought by Resolutions 15 and 16 are used in relation to a non‑pre‑emptive offer, the Directors confirm their intention to follow the shareholder protections in paragraph 1 of Part 2B of the Pre‑emption Group's Statement of Principles 2022 and, where relevant, follow the expected features of a follow‑on offer as set out in paragraph 3 of Part 2B of the Pre‑emption Group's Statement of Principles 2022.

The powers under Resolutions 15 and 16 will expire on the earlier of 24 October 2026 and the conclusion of the AGM of the Company held in 2026.

Resolution 17

Authority to make purchases of own shares

Resolution 17, which will be proposed as a special resolution, seeks to renew the authority granted at last year's AGM and gives the Company authority to buy back its own ordinary shares in the market as permitted by the 2006 Act. The authority limits the number of shares that could be purchased to a maximum of 87,687,078 ordinary shares (representing approximately 14.99% of the issued ordinary share capital (excluding treasury shares)) of the Company as at 19 June 2025 (being the latest practicable date prior to the publication of this Notice). This authority will expire on the earlier of 24 October 2026 and the conclusion of the AGM of the Company held in 2026.

On 14 November 2024, the Company announced its share buy‑back of ordinary shares for up to a maximum aggregate purchase price of £50 million. During the year ended 29 March 2025, as part of this buy‑back programme, the Company purchased a total number of 30,498,221 ordinary shares of 5 pence each for a total consideration of £49,999,991.00, excluding costs. The shares purchased are held in treasury but may be cancelled in due course.

As announced on 10 June 2025, If resolution 17 is passed, the Company intends to undertake a further buyback programme for up to a maximum aggregate purchase price of £50 million. Save in the context of such return of value, the Directors do not currently expect to exercise the authority to make market purchases provided by Resolution 17, if passed. However, the authority provides the flexibility to allow them to do so in the future. The Directors will exercise this authority only when to do so would be in the best interests of the Company and of its shareholders generally, and could be expected to result in an increase in the earnings per share of the Company.

Ordinary shares purchased by the Company pursuant to this authority may either be held as treasury shares or cancelled by the Company and the number of ordinary shares reduced accordingly, depending on which course of action is considered by the Directors to be in the best interest of shareholders at that time. Shares held in treasury may be cancelled, sold for cash or used for the purposes of employee share plans. Once held in treasury, the Company is not entitled to exercise any rights, including the right to attend and vote at meetings, in respect of those shares.

Furthermore, no dividend or other distribution of the Company's assets may be made to the Company in respect of the shares held in treasury.

The minimum price, exclusive of expenses, which may be paid for an ordinary share is 5 pence, its nominal value. The maximum price, exclusive of expenses, which may be paid for an ordinary share is the highest of: (i) an amount equal to 5% above the average market value for an ordinary share for the five business days immediately preceding the date of the purchase and (ii) the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venues where the purchase is carried out.

The Company has options and awards outstanding over 54,057,328 ordinary shares, representing 9.24% of the Company's issued ordinary share capital (excluding treasury shares) as at 19 June 2025 (being the latest practicable date prior to the publication of the Notice). If the authority now being sought by Resolution 17 were to be used in full, the total number of options and awards outstanding would represent 10.87% of the Company's issued ordinary share capital (excluding treasury shares) at that date. As at 19 June 2025 (being the latest practicable date prior to the publication of the Notice), the Company held 165,724,514 ordinary shares in treasury representing 28.33% of the issued ordinary share capital and there are no warrants outstanding.

Resolution 18

Authority to make political donations and political expenditure in the United Kingdom (UK)

Resolution 18 seeks to renew the authority granted at last year's AGM for the Company and its subsidiaries to make political donations to political parties or independent election candidates, to other political organisations, or to incur political expenditure.

It is not the policy of the Company to make donations to UK political organisations or to incur other political expenditure and the Directors have no intention of changing that policy. However, as a result of the broad definition used in the 2006 Act of matters constituting political donations, it is possible that normal business activities, which might not be thought to be political expenditure in the usual sense, could be caught. Accordingly, authority is being sought as a precaution to ensure that the Company's normal business activities do not infringe the 2006 Act.

Under the 2006 Act, this authority may be for a period of up to four years. However, in line with corporate governance best practice, the Company seeks to renew the authority on an annual basis.

Resolution 19

The Sharesave is an all-employee savings-related share option plan designed in accordance with HM Revenue & Customs requirements to deliver tax-favoured share options. A summary of the Sharesave rules is set out in Appendix 2 and a copy of the Sharesave rules will be available for inspection by shareholders on the National Storage Mechanism (accessible at https://data.fca.org.uk/#/nsm/ nationalstoragemechanism) from the date of publication of this Notice and at the place of the Annual General Meeting from 15 minutes prior to its commencement until its conclusion.

Resolution 20

Notice of general meetings

The Directors wish to retain the flexibility and benefit from the ability to call general meetings on 14 clear days' notice and Resolution 20, which is proposed as a special resolution, seeks to renew the authority granted by shareholders at last year's AGM. Such approval will not affect AGMs, which will continue to be held on at least 21 clear days' notice.

In the event that this authority is to be exercised, the Directors will ensure that it is not used as a matter of routine, but only where the flexibility is merited by the business of the meeting and is thought to be to the advantage of shareholders as a whole. The Company undertakes to meet the requirements for a means of electronic voting to be made available to all shareholders before calling a meeting on 14 clear days' notice. The approval will be effective until the Company's next AGM, when it is intended that a similar resolution will be proposed.

Notes to the Notice of Annual General Meeting

Form of Proxy

• 1 A Form of Proxy is enclosed with this Notice and instructions for its completion and return by post or online are shown on the form. In the case of joint holders, any one holder may vote. If more than one holder is present at the AGM, only the vote of the senior will be accepted, seniority being determined by the order in which names appear on the Register of Members.
• 2 A shareholder is entitled to appoint another person as their proxy to exercise all or any of their rights to attend, speak and vote at the AGM. A proxy need not be a shareholder of the Company. A shareholder may appoint more than one proxy in relation to the AGM provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder. If a shareholder does not specify how they want the proxy to vote on any particular resolution, the proxy may vote or abstain as they see fit. A proxy may also vote or abstain as they see fit on any other business which properly comes before the AGM.
• 3 The AGM this year will be held as a physical meeting. Shareholders are strongly encouraged to complete and return the Form of Proxy appointing the Chairman of the meeting as their proxy or vote online in advance of the AGM in order to ensure their votes are counted. Completion and return of such a Form of Proxy will not prevent a shareholder from attending the AGM and voting in person where they are otherwise permitted to do so. Such a vote in person at the AGM will replace any vote previously lodged.

Return date for proxies

4 To be effective, the return of a duly completed postal Form of Proxy (or by electronic means), together with any power of attorney or other authority under which the Form of Proxy is signed (or a notarially certified copy of such authority), must be received by the Company's Registrar, Equiniti, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA no later than 2.30 pm UK time on 23 July 2025 (or, in the event of any adjournment, so as to arrive no later than 48 hours, excluding non‑working days, before the time appointed for the adjourned AGM). Persons voting under a power of attorney must do so using the hard copy Form of Proxy.

Electronic proxy appointments

• 5 Shareholders may, if they so wish, register the appointment of a proxy or proxies electronically by any of the following methods:
  • (A) It is possible for you to submit your proxy votes online by going to Equiniti's Shareview website, www.shareview.co.uk, and logging in to your Shareview Portfolio. Once you have logged in, simply click 'View' on the 'My Investments' page and then click on the link to vote and follow the on-screen instructions. If you have not yet registered for a Shareview Portfolio, go to www.shareview.co.uk and enter the requested information. It is important that you register for a Shareview Portfolio with enough time to complete the registration and authentication processes.
  • (B) If you are an institutional investor, you may be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io. Your proxy must be lodged by 2.30 pm on 23 July 2025 in order to be considered valid. Before you can appoint a proxy via this process you will need to have agreed to Proxymity's associated terms and conditions. It is important that you read these carefully as you will be bound by them, and they will govern the electronic appointment of your proxy.

(C) If you are a member of CREST, by using the CREST electronic appointment service.

CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the AGM (and any adjournment(s) thereof) by using the procedures described in the CREST Manual which can be viewed at www.euroclear.com. CREST personal members or other CREST sponsored members (and those CREST members who have appointed a service provider(s)) should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.

In order for a proxy appointment or instruction made using the CREST service to be valid, the appropriate CREST message (a 'CREST Proxy Instruction') must be properly authenticated in accordance with Euroclear UK & Ireland Limited's specifications, and must contain the information required for such instructions, as described in the CREST Manual. The message, regardless of whether it constitutes the appointment of a proxy or is an amendment to the instruction given to a previously appointed proxy must, in order to be valid, be transmitted so as to be received by the issuer's agent (ID RA19) by 2.30 pm on 23 July 2025. For this purpose, the time of receipt will be taken to be the time (as determined by the time stamp applied to the message by the CREST Application Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.

CREST members (and, where applicable, their CREST sponsors or voting service provider(s)) should note that Euroclear UK & Ireland Limited does not make available special procedures in CREST for any particular message. Normal system timings and limitations will, therefore, apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his/her CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members (and, where applicable, their CREST sponsors or voting system provider(s)) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5) (a) of the Uncertificated Securities Regulations 2001.

Publication of audit concerns

6 Under section 527 of the 2006 Act, shareholders that meet the threshold requirements set out in that section have the right to require the Company to publish on a website a statement setting out any matter relating to: (i) the audit of the Company's accounts (including the auditor's report and the conduct of the audit) that are to be laid before the AGM; or (ii) any circumstance connected with an auditor of the Company ceasing to hold office since the previous meeting at which annual accounts and reports were laid, in each case, that shareholders propose to raise at the AGM. The Company may not require the shareholders requesting any such website publication to pay its expenses in complying with sections 527 or 528 (requirements as to website availability) of the 2006 Act. Where the Company is required to place a statement on a website under section 527 of the 2006 Act, it must forward the statement to the Company's auditor no later than the time when it makes the statement available on the website. The business which may be dealt with at the AGM includes any statement that the Company has been required under section 527 of the 2006 Act to publish on a website.

Attendance and voting

• 7 Entitlement to vote at the AGM and the number of votes which may be cast at the AGM will be determined by reference to the Register of Members of the Company at 6.30 pm UK time on 23 July 2025 (or, in the event of any adjournment, at 6.30 pm UK time on the date which is two business days prior to the adjourned AGM). In each case, changes to the Register of Members after such time will be disregarded.
• 8 Voting at the AGM will be by way of a poll. A poll reflects the number of voting rights exercisable by each member and so the Board considers it a more democratic method of voting. Also see note 3 above.

Right to ask questions

9 Any shareholder entitled to attend the AGM has the right to ask questions. Shareholders are encouraged to submit questions relating to the business of the AGM in advance of the AGM by email to companysecretariat@firstgroup.co.uk.

The Company must cause to be answered any such question relating to the business being dealt with at the AGM, but no such answer need be given if (a) to do so would interfere unduly with the preparation for the AGM or involve the disclosure of confidential information, (b) the answer has already been given on a website in the form of an answer to a question, or (c) it is undesirable in the interests of the Company or the good order of the AGM that the question be answered.

10 Shareholders who have general queries about the AGM should use the following means of communication (no other communication will be accepted): calling the shareholder helpline on telephone number +44 (0) 371 384 2046 Telephone lines are open from 8.30am to 5.30 pm, Monday to Friday. Shareholders may not use any electronic address provided either in this Notice or any related documents (including the Form of Proxy) to communicate with the Company for any purposes other than those expressly stated in those documents.

Extensive information including many answers to frequently asked questions can be found online at www.shareview.co.uk.

Security and safety

11 Security and safety measures will be in place to ensure your safety at the AGM. All those present at the AGM are asked to facilitate the orderly conduct of the meeting and the health and safety of those attending it, and the Company reserves the right, if orderly conduct or attendees' health or safety is threatened by a person's behaviour, to refuse entry to that person or to require that person to leave. All hand baggage may be subject to examination prior to entry to the AGM. Mobile phones may not be used in the AGM and cameras, video recorders, laptop computers and similar equipment may not be taken into the AGM. Anyone attempting to take photos, or to record or film proceedings, may be asked to leave. Attendance at the AGM may also be subject to compliance with all relevant UK Government public health guidance relating to the holding of public gatherings at the relevant time.

Indirect investors and nominated persons

12 Any person to whom this Notice of Meeting is sent who is a person nominated under section 146 of the 2006 Act to enjoy information rights ('Nominated Person') may, under an agreement between them and the shareholder by whom they were nominated, have a right to be appointed (or to have someone else appointed) as a proxy for the AGM.

If a Nominated Person has not been appointed as a proxy for the AGM or does not wish to exercise their right, they may under any such agreement have a right to give instructions to the shareholder as to the exercise of voting rights.

13 The right to appoint a proxy for the AGM referred to in explanatory note 2 can only be exercised by shareholders of the Company and not by a Nominated Person.

Corporate representatives

14 Any corporation which is a member can appoint one or more corporate representatives who may exercise on its behalf all of its powers as a member, provided that they do not do so in relation to the same shares.

Documents available for inspection

15 In addition to the Sharesave rules, which will be available for inspection as set out in the explanatory note to Resolution 19 on page 5 above, the following documents will be available for inspection during usual business hours on any weekday (Saturdays, Sundays and public holidays excluded) at the offices of FirstGroup plc, 8th floor, The Point, 37 North Wharf Road, London, W2 1AF and will also be available for inspection at the place of the AGM from 15 minutes before the AGM until its conclusion: (i) copies of the Executive Directors' service agreements; and (ii) copies of the Non‑Executive Directors' letters of appointment.

Website

• 16 A copy of this Notice, and other information required by section 311A of the 2006 Act, can be found at www.firstgroupplc.com.
• 17 We will ensure that to the extent practicable answers to the questions submitted in advance by email to companysecretariat@firstgroup.co.uk are published on our website at www.firstgroupplc.com.

Voting Results

18 The results of the voting at the AGM will be announced through a RIS and will appear on our website at www.firstgroupplc.com as soon as reasonably practicable.

Notes to the Notice of Annual General Meeting continued

Issued Share Capital and Total Voting Rights

19 As at 19 June 2025 (being the latest practicable date prior to the publication of this Notice), the Company's issued share capital consists of 750,695,015 ordinary shares.

The Company currently holds 165,724,514 of its ordinary shares in treasury. Therefore, the total number of voting rights in the Company as at 19 June 2025 (being the latest practicable date prior to the publication of this Notice) is 584,970,501.

Additional information

20 Shareholders have the right to request the Company to: (i) circulate, to those entitled to receive this notice, additional resolutions to be voted on at the AGM and (ii) include other matters in the business to be dealt with at the AGM, if the shareholders meet the requirements set out in sections 338 and 338A of the 2006 Act. The Company may refuse to circulate a proposed resolution, or to include an additional matter of business, if it is defamatory, frivolous or vexatious or, in the case of a resolution, if it would be ineffective for any reason (for example, it is inconsistent with law or the Company's constitution). A request may be in electronic or paper form. It must state the proposed resolution or the additional matter of business, be authorised by the shareholders making it and be received by the Company no later than 13 June 2025, being the date six clear weeks before the meeting. A request for a matter to be included in the business of the meeting must also be accompanied by a statement setting out the grounds for the request.

Privacy

21 Personal data provided by shareholders at or in relation to the AGM (including names, contact details, votes and Shareholder Reference Numbers), will be processed in line with the Company's privacy policy which is available on our website at www.firstgroupplc.com.

Appendix 1

Directors' biographies

Lena Wilson CBE

Chairman

Appointed:

1 February 2025

Key areas of expertise: CEO, International, Public and private sectors, Energy, Transport,

Financial services, Real Estate, Governance, Transformation

Skills and experience:

Lena joined the FirstGroup plc Board as Chair on 1 February 2025. Lena is an experienced Director and Chair having held roles on listed and private companies for more than 15 years serving on the boards of Scottish Power Renewables Limited and Intertek Group plc and chairing AGS Airports Limited. Lena was Chief Executive of Scottish Enterprise from 2009 to 2017 and prior to that, was a Senior Investment Advisor to The World Bank in Washington DC.

External appointments:

Non-executive director, Senior Independent Director and Remuneration Committee Chair at NatWest Group plc.

Nationality: British

Graham Sutherland

Chief Executive Officer Appointed: 16 May 2022

Key areas of expertise:

Business Strategy, Performance Improvement, Government Contracting, Engineering and Infrastructure, Digital Transformation, Corporate Finance/M&A, Governance

Skills and experience:

Graham has a strong track record in the delivery of critical services and in creating value for shareholders in rapidly evolving regulatory and technological environments. Previously he was Chief Executive Officer of KCOM Group plc, a LSE‑listed telecommunications company. Prior to this, Graham held a number of senior executive roles within BT Group PLC over twelve years. These included as Chief Executive Officer of the BT Business and Public Sector division, where he was responsible for profitable growth and led the integration of EE's Business unit, creating a division with £4.6bn in annual revenues and 13,000 employees. Graham was also Chief Executive of BT Ireland where he was responsible for all consumer, business and network activities. Prior to that he was Chief Executive of NTL Ireland and has also held senior financial roles including at Bombardier. Graham has an established record in strategic development, as well as delivering enhanced financial and operational performance and engaging a diverse range of stakeholders including consumer, business and public sector customers.

External appointments:

Non-executive director at HICL Infrastructure PLC

Nationality: British

Ryan Mangold

N

Chief Financial Officer Appointed:

31 May 2019

Key areas of expertise:

Corporate Finance/M&A, Turnaround, Pensions, Governance

Skills and experience:

Ryan was appointed as CFO in May 2019, having previously been Group Finance Director of Taylor Wimpey Plc for eight years. Ryan has a strong track record of building financial discipline in the organisations he has worked at. During his time at Taylor Wimpey, Ryan played a leading and integral role in strengthening the balance sheet, driving operational improvements, rebuilding the business post the financial crisis (to become a constituent of the FTSE 100), the sale of the North American business and the improvement of its pensions position. Ryan was previously at the Anglo American group of companies, where he was Group Financial Controller at Mondi and played a significant role in its demerger from Anglo American in 2007. Ryan is a chartered accountant and has recent and relevant financial experience.

External appointments:

None

Nationality: South African/British

Sally Cabrini

Independent Non‑Executive Director

Appointed: 24 January 2020

Key areas of expertise: HR, IT, Transformation

Skills and experience:

Sally brings valuable experience in UK regulated utilities, services and manufacturing. She has expertise in delivering business transformation programmes often including internal restructuring, cultural and significant technological changes. As Transformation, IT and People Director at Interserve Group Limited she had a strong focus on effective operational delivery and led a major transformation programme which had significant financial and strategic challenges and prior to that she was a senior executive at FTSE 100 constituent United Utilities with responsibilities for IT, cyber security and people. She was a Non-executive Director and Chair of Remuneration committee at Lookers plc from 2016 to 2020 and at Appreciate Group plc from 2019 to 2023. Sally is a fellow of the Chartered Institute of Personnel and Development.

External appointments:

Non-executive director and Chair of the Remuneration committee of Barchester Healthcare Limited. Pro-Chancellor, Senior Independent Governor and Chair of the Remuneration committee at the University of Exeter.

Nationality:

British

B Responsible Business Committee
E Executive Committee
Chair

E

Appendix 1 continued Directors' biographies continued

Myrtle Dawes

Independent Non‑Executive Director

Appointed: 1 April 2022

Key areas of expertise:

Engineering, Safety, Technology and Digital Transformation, Project Management and Energy Transition

Skills and experience:

Myrtle is an established leader with extensive experience in the energy sector both in the UK and internationally. A chartered Chemical Engineer, she has held a number of senior safety and engineering project management roles in the offshore oil and gas industry, including for BP and BHP Petroleum. Moving to Centrica in 2009, Myrtle performed a number of senior executive roles encompassing engineering, project management, technology and digital transformation including leading the team responsible for safety‑critical, customer facing residential assignments. She holds a Masters in Chemical Engineering and Chemical Technology from Imperial College.

External appointments:

Solution Centre Director for the Net Zero Technology Centre, leading the development of technology for net zero in the energy sector and Non-executive for Aquilla European Renewals plc. Fellow of the Institution of Chemical Engineers, the Energy Institute, the Forward Institute and Honorary Fellow of the Association for Project Management.

Nationality: British

Claire Hawkings

Independent Non‑Executive Director ^{A R B N} Appointed: 21 January 2022

Key areas of expertise:

Sustainability Strategy, Business Transformation, Governance, Commercial Transactions, Performance Management and Energy Transition

Skills and experience:

Claire has more than 30 years' business experience, principally in the energy sector, and has held UK and international leadership positions, most recently with Tullow Oil plc, and prior to that with BG Group plc and British Gas plc. Claire is an environmental scientist and an experienced environmental, social and governance (ESG) professional and holds a degree in Environmental Studies awarded by Northumbria University and an MBA from Imperial College Management School. She is also a Fellow of the Energy Institute. Fellow of the Energy Institute and a Fellow of Chapter Zero.

External appointments:

Non-Executive Director and Chair of the ESG Committee of Ibstock plc, a Non-executive director and Senior Independent Director of James Fisher and Sons plc and a Non-Executive Director of Defence Equipment and Support, a bespoke trading entity and arm's length body of the Ministry of Defence.

Nationality: British

Jane Lodge

A R B N

Independent Non‑Executive Director

Appointed: 30 June 2021

Key areas of expertise:

Transportation/Travel/Engineering and Infrastructure, Corporate Finance/M&A, Governance

Skills and experience:

Jane spent her executive career with Deloitte, where she spent more than 25 years advising multinational companies including businesses in transport, leisure, consumer and technology sectors. Since 2012 she has served as a non‑executive director and audit committee chair at several UK public companies in a range of sectors. Previous roles include non‑executive director of Sirius Minerals plc (2015‑2020, when the company was acquired by Anglo American plc), Costain Group plc and of Devro plc (2012‑2020) and non‑executive director and audit committee chair of DCC plc (2012‑2022). In addition to broad international experience in a range of sectors, Jane brings substantial audit, risk and audit committee expertise to the Board.

External appointments:

Non-executive director, audit committee chair and member of the ESG committee of Bakkavor Group plc; Non-executive director and remuneration committee chair of Glanbia plc; Non-executive director and audit committee chair of Morgan Advanced Materials plc.

Nationality: British

Peter Lynas

Senior Independent Non‑Executive Director

Appointed: 30 June 2021

Key areas of expertise:

Defence and Aerospace, Government Contracting, Turnaround, Corporate Finance/M&A, Pensions, Governance

Skills and experience:

Peter was group finance director of BAE Systems plc (and a director of BAE Systems, Inc.) from 2011 until his retirement in 2020, having previously served in increasingly senior financial and M&A roles since joining the company in 1999. Peter's early career was spent at De La Rue Systems, which he joined as a trainee accountant, and then GEC Marconi from 1985 to 1999, where he became finance director of Marconi Electric Systems. In addition to his strong strategic and financial background Peter brings to the Board extensive experience in heavily regulated industries with significant contractual relationships with government.

External appointments:

Non-executive director of Cohort plc.

Nationality:

British

B Responsible Business Committee
E Executive Committee
Chair

A R B N

Appendix 2

Summary of the principal terms of the rules of the FirstGroup plc Sharesave Plan 2025 (the "Sharesave")

Invitations to apply for options

The Sharesave will be operated by the board of directors, or any committee or person duly authorised by it (the "Board") of FirstGroup plc (the "Company"). Each time that the Board decides to issue an invitation to employees to participate in the Sharesave, all UK resident tax-paying employees and full time directors of the Company and its subsidiaries (the "Group") participating in the Sharesave must be offered the opportunity to participate. Other employees of the Group may be permitted to participate at the Board's discretion. Employees who are invited to participate must have completed a minimum qualifying period of employment (as determined by the Board in line with the relevant legislation governing the Sharesave) before they can participate.

Savings contract

Under the Sharesave, eligible employees may enter into a linked savings contract to make savings over a three or five-year period. Monthly savings by an employee under all savings contracts linked to options granted under any tax-advantaged savings-related share option plan may not exceed the statutory maximum, which is currently set at £500 per month. At the end of the three or five-year savings contract, employees may either withdraw their savings on a tax-free basis or use their savings to acquire ordinary fully paid shares in the Company ("Shares").

Exercise price

The proceeds of the savings contract can be used to exercise an option to acquire Shares at an exercise price per Share set when employees were invited to participate in the Sharesave. The exercise price may not be manifestly less than 80% (or such other percentage as may be permitted by the relevant legislation governing the Sharesave) of the market value of a Share at the date of invitation.

The exercise price will normally be set using share prices taken from the 42-day period beginning on: (a) the first dealing day after the day on which the announcement is made of the Company's results for any period; (b) the day on which the Company holds a general meeting; (c) the day on which an announcement is made of an amendment to the relevant legislation governing the Sharesave or such legislation comes into force; (d) the day on which a new HMRC-approved savings contract is announced; or (e) to the extent that share dealing restrictions apply in any of the preceding periods, the dealing day on which such dealing restrictions are lifted, unless the Board determines that exceptional circumstances exist which justify the issue of invitations under the Sharesave at another time.

Overall limit

The Sharesave may operate over new issue Shares, treasury Shares or Shares purchased in the market. The number of Shares which may be issued or transferred from treasury to satisfy options or awards granted in any ten-year rolling period under the Sharesave and any other employee share plan adopted by the Company may not exceed 10% of the issued ordinary share capital of the Company from time to time. Shares transferred out of treasury will count towards this limit for so long as this is required under institutional shareholder guidelines. However, options over and awards of Shares which are surrendered or lapse will be disregarded for the purposes of this limit.

Exercise of options

Ordinarily, an option may be exercised within six months of the date that the savings contract matures. Options not exercised by participants before the end of the six-month period will lapse.

Cessation of employment

Options will normally lapse immediately when a participant ceases to be employed by the Group. However, if a participant ceases to be employed because of a "good leaver" reason (injury, disability, redundancy, retirement, the sale of the individual's employing company or business out of the Group, or any other reason other than the participant being dismissed for misconduct on or after the third anniversary of the date of grant), their option will not lapse and may be exercised early for a period of up to six months after the participant's cessation of employment. If a participant dies, their option may generally be exercised for 12 months after their death.

Corporate events

In the event of a change of control or winding-up of the Company, any outstanding options may be exercised early. Alternatively, the Board may permit options to be exchanged for equivalent options over shares in the acquiring company. If the change of control is an internal reorganisation of the Group, options will lapse unless the participants agree to exchange their outstanding options for equivalent options over shares in the new holding company.

Adjustments

In the event of a variation of the Company's share capital, the Board may adjust the number of Shares subject to options and/or the exercise price applicable to options in such manner as it considers appropriate.

Rights attached to Shares

Options granted under the Sharesave will not confer shareholder rights on a participant until that participant has exercised their option and received the underlying Shares. Any Shares issued will rank equally with other Shares then in issue (except for rights arising by reference to a record date prior to their issue).

Amendments

The Board may, at any time, amend the Sharesave rules in any respect. The prior approval of the Company's shareholders must be obtained in the case of any amendment which is made to the advantage of eligible employees and/or participants and relates to the provisions relating to eligibility, individual or overall limits, the basis for determining the entitlement to, and the terms of, options granted under the Sharesave, the adjustments that may be made in the event of any variation in the share capital of the Company and/or the rule relating to such prior approval. There are, however, exceptions to this requirement to obtain shareholder approval for any minor amendments to benefit the administration of the Sharesave, to take account of the provisions of any relevant legislation, or to obtain or maintain favourable tax, exchange control or regulatory treatment for any participant or member of the Group.

Non-transferability

Options are not transferable other than to the participant's personal representatives in the event of the participant's death.

Benefits not pensionable

Any benefits received under the Sharesave are not pensionable.

Registered office

FirstGroup plc 395 King Street Aberdeen AB24 5RP

Tel. +44 (0)1224 650100 Registered in Scotland

number SC157176

www.firstgroupplc.com

Corporate office

FirstGroup plc 8th Floor, The Point, 37 North Wharf Road London W2 1AF

Tel. +44 (0)20 7291 0505